Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP28 1 VANCOUVER, BC , June 6, 2026 /PRNewswire/ -- Synbio Tech Inc. (SynbioTech), a global leader in biotechnology solutions, today announced the launch of SYNMUETM, a clinically validated probiotic featuring Lactiplantibacillus plantarum LP28, designed to target immune aging, also known as immunosenescence. The company will showcase SYNMUETM at Probiota Americas 2026, taking place June 8–10 in Vancouver, Canada,